Navigation Links
Facial Aesthetics (Botox, Dermal Fillers, Collagen) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Date:9/5/2011

Forecast, 2010–2017 27

6.5 Facial Aesthetics Market, Italy, Revenue ($m), Forecast, 2010–2017 29

6.6 Facial Aesthetics Market, Spain, Revenue ($m), Forecast, 2010–2017 31

6.7 Facial Aesthetics Market, Japan, Revenue ($m), Forecast, 2010–2017 33

6.8 Facial Aesthetics Market, China, Revenue ($m), Forecast, 2010–2017 35

6.9 Facial Aesthetics Market, India, Revenue ($m), Forecast, 2010–2017 37

6.10 Facial Aesthetics Market, Australia, Revenue ($m), Forecast, 2010–2017 39

6.11 Facial Aesthetics Market, Brazil, Revenue ($m), Forecast, 2010–2017 41

7 Facial Aesthetics Market – Strategic Competitive Assessment 43

7.1 Facial Aesthetics Market, the US, Company Share, 2010 43

7.2 Facial Aesthetics Market, Europe, Company Share, 2010 44

7.3 Facial Aesthetics Market, Asia-Pacific, Company Share, 2010 45

7.4 Facial Aesthetics Market, Key Market Participants 47

7.4.1 Allergan, Inc 47

7.4.2 Q–Med AB 49

7.4.3 Mentor Corporation 51

7.4.4 Medicis Pharmaceuticals Corporation 53

7.4.5 BioForm Medical, Inc 54

8 Facial Aesthetics Market – Strategic Pipeline Assessment 56

8.1 Facial Aesthetics Market, Pipeline Assessment, by Development Stage 56

8.2 Profiles of Pipeline Products in Facial Aesthetics Market 58

8.2.1 Contura International A/S: Aquamid 58

8.2.2 Celltrix AB: Credurance 58

8.2.3 Albiorex: Humallagen Dermal Filler 58

8.2.4 Allergan, Inc.: Juvederm Voluma 59

8.2.5 Q-Med AB: Macrolane 59

8.2.6 Genzyme Corporation: NADGL 60

8.2.7 Anika Therapeutics, Inc.: Next Generation ELEVESS Dermal Filler 60

8.2.8 Merz GmbH & Co. KGaA: Novabel-Dermal Bead 60

8.2.9 Prollenium Medical Technologies, Inc: Revanesse Ultra 61

8.2.10 JUVENIS LTD.: Tenergel 61

8.2.11 FibroGen, Inc.: FG-5030 61

8.2.12 TEI Bioscienc
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. I Wanna Be Sublated™ Road to Rejuvenation™ World Tour Prepares to Rock All Ages Through a New Facial Rejuvenation Category.
2. Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011
3. KLS Martins SonicWeld Rx Changing the Face of Craniomaxillofacial Plate Fixation
4. Facial Injectables Emerge From the Recession
5. CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
6. Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles
7. Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ)
8. Clinical Data Demonstrates 5-Year Efficacy and Safety of Aquamid(R) in Facial Augmentation
9. Molecular Therapy Succeeds in Preventing Craniofacial Birth Defect in Mice
10. Data Demonstrate that Obagi Medical Products Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures
11. Promising Results in Treating Facial Bruising From Injectables
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... shares have been approved for listing and trading on the ... ESSA will begin trading on NASDAQ on July 9, 2015.  ... Exchange under the symbol "EPI". As a result ... each of the Company,s outstanding special warrants issued on January ...
(Date:7/2/2015)... July 2, 2015  Fort Lauderdale-based investment banking ... announce that its Consumer Group completed the sale ... Group plc (ISE: KRZ) ("Kerry"), one of the ... systems, as well as functional ingredients and actives ... Farlie Turner served as the exclusive financial advisor ...
(Date:7/2/2015)... NEW YORK , July 2, 2015 /PRNewswire/ ... of a conspicuously high-growth market segment in hematology ... research publisher said that Roche,s recent unveiling of its ... into the cobas m 511 hematology ... not only capture growth enjoyed by current leader ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
... percent of patients treated with VELCADE, cyclophosphamide,and ... Greece, June 28, 2007 /PRNewswire-FirstCall/ -- Millennium,Pharmaceuticals, ... results,from clinical trials of VELCADE based therapies ... (CR) rates in previously,treated multiple myeloma (MM) ...
... 29, 2007 /PRNewswire/ --,The European Myeloma Platform (EMP) ... (lenalidomide) plus the,steroid dexamethasone shows median survival of ... from two large randomized,controlled Phase III trials that ... sites worldwide. These updated results,were presented at the ...
Cached Medicine Technology:Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6The European Myeloma Platform Reports New Survival data for,Revlimid Presented at the International Myeloma Workshop in Greece 2
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The ... he says will reveal biblical truth and expose popular lies regarding proper relationships according ... Don’t Have Sex”, immediately goes into the core of the subject by explaining why ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to ... the 19th sweetFrog store located in the Lone Star State. The premium frozen yogurt ... in 2014. , The store, which opened July 1 at Duke’s Travel Plaza, is ...
(Date:7/2/2015)... , ... July 02, 2015 , ... With summer in full swing, Americans are flocking ... one of the top spots for fishing in the world, and it’s easy to understand ... Ontario, Canada has great fish. , Recreational fishing is a huge industry, and Americans ...
(Date:7/2/2015)... ... July 02, 2015 , ... Global leader and compression innovator, ... designed for men. , For style that’s quick on its feet, men will ... is great news for men everywhere because a simple change in socks can dramatically ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... provides comprehensive information on the pipeline products with comparative analysis of the ... therapy (NPWT) with 22 market data tables and 4 figures, spread across ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4
... use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) ... men with prostate cancer, say researchers at Vanderbilt University. ... Health Study included 1,277 participants referred to a urologist ... of the men reported taking an NSAID, mostly aspirin ...
... long-term, randomized clinical trial that included 14,641 physicians who were ... given 400 IU of vitamin E every other day or ... its placebo. , Researchers followed these patients for up ... rates of completion of annual questionnaires, and the confirmation of ...
... characterized as being in "denial" not recognizing the ... to be a form of deception, emerging research suggests ... dysfunction similar to that observed in other neuropsychiatric illnesses. ... relevant research during a symposium on "Impaired Insight into ...
... DPL™ Therapy System for temporary relief of pain. , ... ... announced today that the U.S. Food and Drug Administration (FDA) cleared ... of muscle spasms, temporary relief of minor muscle and joint aches, ...
... A protein known to inhibit the growth of ovarian ... themselves until they die, researchers at The University of Texas ... issue of Cancer Research . , The research team ... is an independent indicator of a woman,s prospects for surviving ...
... Finding may explain why treatment and outcomes are different among ... lung tumors tend to have a different genetic makeup in ... treatment and outcomes are different among races, a new study ... to carry more copies of the epidermal growth factor receptor ...
Cached Medicine News:Health News:Men who take aspirin have significantly lower PSA levels 2Health News:Men who take aspirin have significantly lower PSA levels 3Health News:No protective effect on cancer from long-term vitamin E or vitamin C supplementation 2Health News:'Insight' deficit may explain denial in drug addiction 2Health News:'Insight' deficit may explain denial in drug addiction 3Health News:FDA Clears the DPL (Deep Penetrating Light) Therapy System for Over-the-Counter - Home Use 2Health News:Protein compels ovarian cancer cells to cannibalize themselves 2Health News:Lung Cancer Genetics Different in Black Patients: Study 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: